MENLO PARK, Calif. (AP) — Pacific Biosciences of California Inc. (PACB) on Tuesday reported a loss of $24.6 million in its second quarter.

The Menlo Park, California-based company said it had a loss of 16 cents per share.

The maker of genetic analysis technology posted revenue of $24.6 million in the period, beating Street forecasts. Three analysts surveyed by Zacks expected $22.3 million.

Pacific Biosciences shares have fallen 26% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $5.49, an increase of 43% in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on PACB at

Automated Insights

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.